Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

STRATA Skin Sciences (SSKN) Operating Expenses (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Operating Expenses for 14 consecutive years, with $5.1 million as the latest value for Q4 2025.

  • Quarterly Operating Expenses fell 48.98% to $5.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.6 million through Dec 2025, down 20.7% year-over-year, with the annual reading at $22.6 million for FY2025, 20.7% down from the prior year.
  • Operating Expenses hit $5.1 million in Q4 2025 for STRATA Skin Sciences, down from $5.4 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $10.0 million in Q4 2024 to a low of $5.1 million in Q4 2025.
  • Historically, Operating Expenses has averaged $6.4 million across 5 years, with a median of $6.4 million in 2022.
  • Biggest five-year swings in Operating Expenses: surged 58.82% in 2021 and later plummeted 48.98% in 2025.
  • Year by year, Operating Expenses stood at $6.6 million in 2021, then grew by 1.39% to $6.7 million in 2022, then increased by 22.76% to $8.2 million in 2023, then increased by 21.91% to $10.0 million in 2024, then tumbled by 48.98% to $5.1 million in 2025.
  • Business Quant data shows Operating Expenses for SSKN at $5.1 million in Q4 2025, $5.4 million in Q3 2025, and $6.6 million in Q2 2025.